Skip to main content
OpenTrials
Completed

NCT Number: NCT07564791

A Study to Evaluate the Effects of the Libido Lift Supplement on Libido and Sexual Desire in Men

This study evaluates the effects of the Libido Lift supplement on libido and sexual desire in men aged 35-75 years. Participants will be randomized to receive either the supplement or placebo for 4 weeks, with outcomes assessed באמצעות questionnaires at multiple timepoints.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Low Libido Behavior Coitus Sexual Behavior Sexual; Desire Absent

Age range

35 year–75 year

Sex eligibility

Male

Study type

Interventional

Phase

Not applicable

Primary location

Citruslabs

Las Vegas, Nevada, 89118, United States

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Male
  • Aged 35-75 years
  • Low sexual desire or desire to improve libido
  • Dissatisfaction with sex life or desire to improve intimacy
  • Desire to improve energy, endurance, stamina
  • Sexually active (≥2 times per week)
  • Willing to comply with study requirements
  • Generally healthy
  • Resides in the United States

Exclusion criteria

  • Recent surgery or major illness
  • Heavy alcohol use
  • Hormone-related medications
  • Liver disease or hypertension
  • Use of anticoagulants
  • Allergies to ingredients
  • Chronic conditions affecting participation
  • Participation in another study
  • History of substance abuse

Treatment and study plan

Dietary Supplement: Libido Lift

Dietary Supplement

Four capsules taken once daily in the morning with water.

Placebo

Dietary Supplement

Four placebo capsules taken once daily in the morning with water.

Primary outcomes

  1. Change in Libido and Sexual Desire Score

    Time frame: Baseline, Week 1, Week 2, Week 3, Week 4

    Libido and sexual desire will be assessed using study-specific self-reported questionnaires. Questionnaire responses will be used to generate a score reflecting participants' level of libido and sexual desire. Changes in scores over time will be used to evaluate the effect of the intervention. Higher scores indicate greater libido and sexual desire.

Secondary outcomes

  1. Change in Self-Reported Sexual Satisfaction

    Time frame: Baseline, Week 1, Week 2, Week 3, Week 4

    Assessed via questionnaire responses evaluating satisfaction with sexual experiences.

  2. Change in Self-Reported Intimacy

    Time frame: Baseline, Week 1, Week 2, Week 3, Week 4

    Measured using questionnaires assessing perceived emotional and physical intimacy.

  3. Change in Self-Reported Energy Levels

    Time frame: Baseline, Week 1, Week 2, Week 3, Week 4

    Assessed via questionnaire items evaluating perceived energy.

Sponsors and collaborators

Lead sponsor

Bio Nature Health

Industry

Collaborators

  • Citruslabs

Registry information

Important dates

Study start
2025
Primary completion
2025
Study completion
2025
First posted
May 4, 2026
Registry last updated
May 4, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.